Loading...
Nitric oxide and pulmonary arterial hypertension.
Chester, A Yacoub, M Moncada, Salvador
Chester, A
Yacoub, M
Moncada, Salvador
Citations
Altmetric:
Abstract
The pathogenesis of pulmonary arterial hypertension remains undefined. Changes in the expression and effects mediated by a number of vasoactive factors have been implicated to play a role in the onset and progression of the disease. The source of many of these mediators, such as nitric oxide (NO), prostacyclin and endothelin-1 (ET-1), is the pulmonary endothelium. This article focus in the role of nitric oxide in PAH, reviewing the evidence for its involvement in regulation of pulmonary a vascular tone under physiological conditions, the mechanisms by which it can contribute to the pathological changes seen in PAH and strategies for the use of NO as a therapy for treatment of the disease.
Authors
Description
Date
2017-06-30
Publisher
Collections
Files
Keywords
Type
Article
Citation
Nitric oxide and pulmonary arterial hypertension. 2017, 2017(2): 14 Glob Cardiol Sci Pract